PRPH
ProPhase Labs, Inc.Company Information
- Company Name
- ProPhase Labs, Inc.
- CIK
- CIK0000868278
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- PRPH: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- PRPH
SEC filing data through
Insider Sentiment
- Last purchase
- 2022-03-10
- Last sale
- 2020-08-13
- Shares purchased (TTM)
- 35,414
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2025-12-31
- Institutional shares owned
- 207,511
- Shares outstanding
- 8,489,000
- Ownership
- 2.44%
Earnings Market Reaction
- Filing date
- 2026-08-19
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Affiliated Entity | - | - | 28 | 28 | - | - | 0 | - | - | - | - | - | ||||||
| Marketable Securities Current | - | - | 0 | - | - | - | 0 | 0 | 0 | 0 | 3 | 3 | ||||||
| Restricted Cash | - | - | - | - | - | - | - | - | - | - | 1 | - | ||||||
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 2 | 1 | ||||||
| Restricted Cash Current | - | - | - | - | - | - | - | 1 | 1 | 1 | - | - | ||||||
| Available For Sale Securities Debt Securities Current | - | - | - | - | 0 | - | - | - | - | - | - | - | ||||||
| Accounts Receivable Net Current | 2 | 2 | 2 | 3 | 20 | 20 | 20 | 32 | 33 | 35 | 36 | 39 | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 4 | 4 | 4 | 2 | 5 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 4 | 3 | 3 | 3 | 6 | 5 | 4 | 2 | 3 | ||||||
| Assets Of Disposal Group Including Discontinued Operation Current | - | - | 0 | 0 | 0 | 0 | 6 | - | - | - | 3 | - | ||||||
| Assets Current | 3 | 3 | 3 | 8 | 25 | 25 | 31 | 42 | 44 | 45 | 48 | 50 | ||||||
| Property Plant And Equipment Net | 1 | 2 | 2 | 2 | 4 | 7 | 8 | 14 | 15 | 13 | 10 | 13 | ||||||
| Equity Method Investments | 43 | 43 | 43 | 44 | - | - | 0 | - | - | - | - | - | ||||||
| Deferred Income Tax Assets Net | - | - | - | - | - | - | 0 | 15 | 12 | 10 | 7 | 4 | ||||||
| Prepaid Expense Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | - | - | 0 | 0 | 0 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | ||||||
| Intangible Assets Net Excluding Goodwill | 6 | 7 | 7 | 8 | 8 | 9 | 10 | 10 | 11 | 12 | 12 | 13 | ||||||
| Goodwill | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | ||||||
| Disposal Group Including Discontinued Operation Assets Noncurrent | - | - | 0 | 0 | 0 | 0 | 5 | - | - | - | 3 | - | ||||||
| Assets | 57 | 58 | 60 | 66 | 42 | 50 | 63 | 92 | 94 | 90 | 92 | 92 | ||||||
| Accounts Payable Current | - | - | - | - | 15 | 13 | 14 | 15 | 14 | 12 | 9 | 5 | ||||||
Liabilities Current | ||||||||||||||||||
| Accrued Professional Fees Current | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accrued Marketing Costs Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finance Lease Liability Current | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 4 | 4 | 2 | 2 | 2 | ||||||
| Operating Lease Liability Current | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Deferred Revenue Current | - | - | - | - | - | - | - | - | - | - | 2 | 2 | ||||||
| Short Term Borrowings | - | - | - | - | - | 2 | 3 | 3 | 3 | 2 | 0 | - | ||||||
| Convertible Debt Current | 0 | 0 | 0 | 1 | - | - | 0 | - | - | - | - | - | ||||||
| Derivative Liabilities Current | 1 | 0 | 0 | 3 | - | - | 0 | - | - | - | - | - | ||||||
| Contract With Customer Liability Current | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | - | ||||||
| Taxes Payable Current | 1 | 1 | 0 | 0 | 1 | 1 | 2 | 2 | 3 | 3 | 3 | 3 | ||||||
| Other Liabilities Current | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | ||||||
| Long Term Debt Noncurrent | - | - | - | - | - | - | - | - | - | - | 3 | - | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | - | - | 0 | 0 | 0 | 0 | 6 | - | - | - | 1 | - | ||||||
| Liabilities Current | 58 | 56 | 53 | 55 | 26 | 24 | 32 | 29 | 28 | 24 | 21 | 16 | ||||||
| Secured Long Term Debt | - | - | - | - | - | - | - | 3 | 3 | 3 | - | - | ||||||
| Unsecured Long Term Debt | - | - | - | - | - | - | - | - | 7 | 7 | - | - | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Deferred Income Tax Liabilities Net | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Asset Acquisition Contingent Consideration Liability Noncurrent | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Contract With Customer Liability Noncurrent | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Noncurrent | - | - | 0 | 0 | 0 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | ||||||
| Finance Lease Liability Noncurrent | 0 | 0 | 1 | 1 | 2 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Noncurrent | - | - | 0 | 0 | 0 | 0 | 3 | - | - | - | 3 | - | ||||||
| Liabilities Noncurrent | 2 | 3 | 3 | 4 | 5 | 11 | 24 | 25 | 22 | 21 | 22 | 19 | ||||||
| Liabilities | 61 | 59 | 56 | 59 | 31 | 35 | 56 | 54 | 50 | 45 | 43 | 35 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 128 | 128 | 126 | 122 | 120 | 120 | 130 | 126 | 126 | 120 | 119 | 118 | ||||||
| Stockholders Equity Note Subscriptions Receivable | - | - | - | - | - | -0 | - | - | - | - | - | - | ||||||
| Retained Earnings Accumulated Deficit | -81 | -78 | -73 | -66 | -59 | -54 | -58 | -24 | -17 | -11 | -5 | 4 | ||||||
| Treasury Stock Common Value | -50 | -50 | -50 | -50 | -50 | -50 | -64 | -64 | -64 | -64 | -64 | -64 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1 | ||||||
| Stockholders Equity | -3 | -0 | 4 | 7 | 11 | 15 | 7 | 38 | 44 | 45 | 49 | 56 | ||||||
| Liabilities And Stockholders Equity | 57 | 58 | 60 | 66 | 42 | 50 | 63 | 92 | 94 | 90 | 92 | 92 | ||||||
| A2023 Secured Mortgage Loan | - | - | - | - | - | - | - | 0 | - | - | - | - | ||||||
| Debt Instrument Unamortized Discount Current | - | - | - | - | - | 0 | 0 | 0 | 1 | 0 | - | - | ||||||
| Debt Instrument Unamortized Discount Noncurrent | - | - | - | - | - | - | - | - | 0 | 0 | 0 | - | ||||||
| Nonrelated Party | - | - | 13 | 14 | 0 | - | 14 | - | - | - | - | - | ||||||
| Related Party | - | - | 13 | 14 | 0 | - | 14 | - | - | - | - | - | ||||||
| Loans Payable | - | - | 0 | 1 | - | 2 | 0 | 2 | - | - | - | - | ||||||
| Convertible Notes Payable | - | - | 0 | 3 | - | - | - | - | - | - | - | - | ||||||
| J X V I I Note | - | - | 0 | 0 | 0 | - | 0 | -0 | -0 | 0 | 0 | - | ||||||
| A2023 Note | - | - | - | - | - | - | - | - | - | - | 0 | -0 | ||||||
| September Two Thousand And Twenty Note | - | - | - | - | - | - | - | - | - | - | 0 | -2 | ||||||
| E R C Claim | - | - | 0 | -0 | -0 | 0 | 0 | 0 | - | - | 0 | - | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Shares Authorized | 1,000 | 1,000 | 1,000 | 50 | 50 | 50 | 1,000 | 50 | 50 | 50 | 50 | 50 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Shares Outstanding | 14 | 14 | 9 | 4 | 4 | 4 | 3 | 2 | 2 | 2 | 2 | 2 | ||||||
| Treasury Stock Common Shares | 1 | 1 | 1 | 1 | 9 | 9 | 1 | 2 | 2 | 2 | 2 | 2 | ||||||
| Stock Issued During Period Shares Treasury Stock Reissued | - | - | - | 1 | 6 | - | 1 | - | - | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialProPhase Labs, Inc. (PRPH) — SEC Financial Statements & Analysis
ProPhase Labs, Inc. (PRPH) is a pharmaceutical preparations company, incorporated in DE. ProPhase Labs, Inc. trades on OTC as: PRPH. ProPhase Labs, Inc. (PRPH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-19. Based on that filing, ProPhase Labs, Inc. carries a market cap of $1.26M, a P/E ratio of -0.06x, a P/B ratio of -0.41x, a P/S ratio of 0.33x, an enterprise value of $5.21M, and an EV/EBITDA multiple of -0.45x. On profitability, it posts a gross margin of 16.77%, an operating margin of -404.50%, a net margin of -583.91%, a Return on Equity (ROE) of -539.65%, a Return on Assets (ROA) of -45.17%, and a Return on Invested Capital (ROIC) of -180.60%. Per share, it reports EPS of $-1.60, diluted EPS of $-1.60, free cash flow per share of $-0.40, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -31.16% year-over-year, net income growth of -45.81% year-over-year, and EPS growth of -83.94% year-over-year. On the balance sheet, it maintains a current ratio of 0.05x, a quick ratio of 0.03x, working capital of $-55.28M, a debt-to-equity ratio of -19.45x, a debt ratio of 1.05, an interest coverage ratio of -2.15x, free cash flow of $-5.54M (TTM), and net debt of $3.95M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.26M
- P/E TTM
- -0.06x
- EPS TTM
- $-1.60
- P/B TTM
- -0.41x
- ROE TTM
- -539.65%
- ROA TTM
- -45.17%
- Debt To Equity
- -19.45x
- Free Cash Flow TTM
- $-5.54M
- Net Revenue TTM Growth 1Y
- -31.16%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ProPhase Labs, Inc. in?
ProPhase Labs, Inc. (PRPH) operates in the Pharmaceutical Preparations industry.
What exchange does PRPH trade on?
ProPhase Labs, Inc. (PRPH) trades on the OTC.
Where is ProPhase Labs, Inc. incorporated?
ProPhase Labs, Inc. is incorporated in DE.
When was ProPhase Labs, Inc. (PRPH)'s most recent SEC filing?
ProPhase Labs, Inc. (PRPH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-19.
What is PRPH's market cap?
ProPhase Labs, Inc. (PRPH) has a market capitalization of $1.26M as of 2026-06-30.
What is PRPH's EPS (earnings per share)?
ProPhase Labs, Inc. (PRPH)'s trailing twelve month EPS is $-1.60 as of 2026-06-30.
What is PRPH's ROE (return on equity)?
ProPhase Labs, Inc. (PRPH)'s trailing twelve month Return on Equity (ROE) is -539.65% as of 2026-06-30.
What is PRPH's ROA (return on assets)?
ProPhase Labs, Inc. (PRPH)'s trailing twelve month Return on Assets (ROA) is -45.17% as of 2026-06-30.
What is PRPH's ROIC (return on invested capital)?
ProPhase Labs, Inc. (PRPH)'s trailing twelve month Return on Invested Capital (ROIC) is -180.60% as of 2026-06-30.
What is PRPH's EV/EBITDA?
ProPhase Labs, Inc. (PRPH)'s trailing twelve month EV/EBITDA is -0.45x as of 2026-06-30.